New York, NY -- (SBWIRE) -- 08/21/2013 -- StockMarketIntel.com issues a special report on the following stocks: Nuvilex Inc (OTCMKTS:NVLX), Pershing Gold Corp (OTCMKTS:PGLC), BluForest Inc (OTCMKTS:BLUF), Titan Pharmaceuticals, Inc. (OTCBB:TTNP)
Nuvilex Inc (OTCMKTS:NVLX) gained 2.40%, trading on 1.44 million shares, to end the trade at $0.149. The stock changed hands in a range of $0.14 to $0.15, bringing its market capitalization to about $76.23 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.02 and was moved to the maximum level of $0.22. Nuvilex, Inc. (NVLX) just acquired oncology assets that make this small Silver Spring, Maryland, biotech worth more than it was just a month ago. This investment could prove to be a genius move on the scale one might see from the "Oracle of Omaha," Warren Buffet. Make no mistake about it, Nuvilex is investing big in its own future and doing so piece by piece.
What was the Moving Force behind NVLX on Bullish Run? Read This Research Report
Pershing Gold Corp (OTCMKTS:PGLC) declined -1.43%, to complete the trading session at $0.345, with a total volume of 628,586 shares. The stock, on average, trades on a volume of 417,613 shares. It floated in a range of $0.34 to $0.35 during the last trading session, with a beta value of 2.77. Its market capitalization now moved to about $94.29 million. In the past 52 weeks, the share price has not declined below $0.30 and above $0.62. Pershing Gold Corporation (PGLC) announced y that it has raised approximately $9.0 million through the sale of Series E Convertible Preferred Stock and warrants pursuant to subscription agreements with certain accredited investors.
Has PGLC Found The Bottom and Ready To Move Up? Find Out Here
BluForest Inc (OTCMKTS:BLUF) recorded a fall of -8.40% and was in a range of $1.11-$1.35 before closing at $1.20. The stock completed the day with a total volume of 277,863shares, versus an average volume of 252,515 shares. The share price hit its 52-week low of $0.11 and $157.50 was the best price. BluForest, Inc. (BLUF) shareholder, George Sharp, announced that Jim Can of Calgary has been added as an additional defendant to a civil action for Fraud, Negligent Misrepresentation, and Deceit, against BluForest and several of its past and present officers, including Gary Alexander, Branislav Jovanovic, and Charles Miller. The Complaint was filed by George Sharp in the San Diego County Division of California Superior Court (Case No. 37-2013-00057730-CU-FR-CTL) on July 16, 2013.
Has BLUF Found The Bottom And Ready To Gain Momentum? Find Out Here
Titan Pharmaceuticals, Inc. (OTCBB:TTNP) added 0.47% yesterday, bringing its market capitalization around $52.36 million. The share price, after opening at $0.64, made a high of $0.65 and hovered above $0.63 to end the day at $0.540. The total number of shares that changed hands during the session was 341,605 shares, as compared to average trading volume of 258,654shares. Titan Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing proprietary therapeutics for the treatment of serious medical disorders in the United States. The company offers Fanapt (iloperidone), an atypical antipsychotic for the treatment of schizophrenia. It is involved in developing Probuphine, an investigational subdermal implant for the treatment of opioid dependence.
For How Long TTNP will fight for Profitability? Read This Trend Analysis report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)